Inspira Technologies’ Breakthrough in Blood Oxygenation

Inspira Technologies Oxy BHN (IINN) has released an update.

Inspira Technologies has achieved a significant milestone by securing a second U.S. patent for its VORTX™ blood oxygenation system, a key component of the INSPIRA™ ART device, which aims to revolutionize the $19 billion mechanical ventilation market. The technology promises to oxygenate blood more safely and cost-effectively by avoiding damage caused by traditional fiber-based systems, potentially benefiting 20 million ICU patients with respiratory failure annually. The company’s innovative approach may allow patients to remain conscious during treatment, providing an alternative to mechanical ventilators which often require sedation and intubation.

For further insights into IINN stock, check out TipRanks’ Stock Analysis page.